Literature DB >> 22811819

Low prevalence of invasive adenocarcinoma and occult cancer on esophageal resection for Barrett's esophagus with high-grade dysplasia: Evidence for conservative management.

Deepa T Patil1, Thomas P Plesec, John R Goldblum.   

Abstract

Entities:  

Year:  2011        PMID： 22811819      PMCID： PMC3397589          DOI： 10.3978/j.issn.2078-6891.2011.003

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  25 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Predictive factors of coexisting cancer in Barrett's high-grade dysplasia.

Authors:  C Tharavej; J A Hagen; J H Peters; G Portale; J Lipham; S R DeMeester; C G Bremner; T R DeMeester
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

Review 3.  Endoscopic therapy for Barrett's esophagus.

Authors:  Richard E Sampliner
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-21       Impact factor: 11.382

4.  Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up.

Authors:  Elizabeth Montgomery; Mary P Bronner; Joel K Greenson; Marian M Haber; John Hart; Laura W Lamps; Gregory Y Lauwers; Audrey J Lazenby; David N Lewin; Marie E Robert; Kay Washington; John R Goldblum
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

5.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia.

Authors:  T G Schnell; S J Sontag; G Chejfec; G Aranha; A Metz; S O'Connell; U J Seidel; A Sonnenberg
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

6.  Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.

Authors:  N S Buttar; K K Wang; T J Sebo; D M Riehle; K K Krishnadath; L S Lutzke; M A Anderson; T M Petterson; L J Burgart
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

7.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

Authors:  B J Reid; D S Levine; G Longton; P L Blount; P S Rabinovitch
Journal:  Am J Gastroenterol       Date:  2000-07       Impact factor: 10.864

8.  Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making.

Authors:  J W van Sandick; J J van Lanschot; F J ten Kate; G J Offerhaus; P Fockens; G N Tytgat; H Obertop
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

9.  Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus.

Authors:  Daniel S Oh; Jeffrey A Hagen; Parakrama T Chandrasoma; Christy M Dunst; Steven R Demeester; Mohammad Alavi; Cedric G Bremner; John Lipham; Christian Rizzetto; Richard Cote; Tom R Demeester
Journal:  J Am Coll Surg       Date:  2006-06-22       Impact factor: 6.113

10.  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.

Authors:  D S Levine; R C Haggitt; P L Blount; P S Rabinovitch; V W Rusch; B J Reid
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682
View more
  1 in total

Review 1.  Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all?

Authors:  Giovanni Zaninotto; Cathy Bennett
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.